Anesthesiology · 2019 · 12 citations · 6 references
MedicineHematologyInternal MedicineHematology PhysiologyHemostasisTransfusion MedicineBlood Transfusion ManagementBlood TypingPretransfusion TestingRed Blood Cell TransfusionTransfusion ReactionsTransfusion TherapyAbo Blood Group AntigensAbo Blood Group TypingBleedingBlood Group Compatibility TestingBlood Type MatchingCohort Study InvestigationForward TypingUncrossmatched Blood Use
BACKGROUND: Group O erythrocytes and/or whole blood are used for urgent transfusions in patients of unknown blood type. This study investigated the impact of transfusing increasing numbers of uncrossmatched type O products on the recipient's first in-hospital ABO type. METHODS: This was a retrospective cohort study. Results of the first ABO type obtained in adult, non-type O recipients (i.e., types A, B, AB) after receiving at least one unit of uncrossmatched type O erythrocyte-containing product(s) for any bleeding etiology were analyzed along with the number of uncrossmatched type O erythrocyte-containing products administered in the prehospital and/or in hospital setting before the first type and screen sample was drawn. RESULTS: There were 10 institutions that contributed a total of 695 patient records. Among patients who received up to 10 uncrossmatched type O erythrocyte-containing products, the median A antigen agglutination strength in A and AB individuals on forward typing (i.e., testing the recipient's erythrocytes for A and/or B antigens) was the maximum (4+), whereas the median B antigen agglutination strength among B and AB recipients of up to 10 units was 3 to 4+. The median agglutination strength on the reverse type (i.e., testing the recipient's plasma for corresponding anti-A and -B antibodies) was very strong, between 3 and 4+, for recipients of up to 10 units of uncrossmatched erythrocyte-containing products. Overall, the ABO type of 665 of 695 (95.7%; 95% CI, 93.9 to 97.0%) of these patients could be accurately determined on the first type and screen sample obtained after transfusion of uncrossmatched type O erythrocyte-containing products. CONCLUSIONS: The transfusion of smaller quantities of uncrossmatched type O erythrocyte-containing products, in particular up to 10 units, does not usually interfere with determining the recipient's ABO type. The early collection of a type and screen sample is important.
6
Detection of anti‐D in D– recipients transfused with D+ red blood cells
Mark H. Yazer, Darrell J. Triulzi · Transfusion · 2007 · 136 citations
Medicine, Hematology, Immunology +12
Probability of anti‐D development in D− patients receiving D+ RBCs
Christoph Frohn, Lutz Dümbgen, Jörg‐Matthias Brand et al. · Transfusion · 2003 · 133 citations · Full text
Ashley C. McGinity, Caroline Zhu, Leslie Greebon et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 2018 · 107 citations